Taysha Gene Therapies, Inc. TSHA
NASDAQ · United States · Health Technology
$4.74-0.13 (-2.67%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-11 | -0.13 | -0.11 | -14.8% | $0 | -100.0% | +0.5%$6.37→$6.41 |
| Q1 2026 | 2026-05-06 | -0.12 | -0.10 | -20.0% | — | — | -3.9%$6.94→$6.67 |
| Q4 2025 | 2026-03-19 | -0.07 | -0.10 | +30.0% | — | — | -1.1%$4.45→$4.40 |
| Q3 2025 | 2025-11-04 | -0.09 | -0.09 | 0.0% | — | — | -9.6%$4.46→$4.03 |
| Q2 2025 | 2025-08-12 | -0.08 | -0.07 | -14.3% | — | — | — |
| Q1 2025 | 2025-05-15 | -0.07 | -0.09 | +22.2% | — | — | — |
| Q4 2024 | 2025-02-26 | -0.07 | -0.08 | +12.5% | — | — | — |
| Q3 2024 | 2024-11-13 | -0.07 | -0.09 | +22.2% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.